Medicare links up with private payers, expands colorectal cancer screening benefit

Why This Topic Matters

The policy changes can affect patient cost-sharing, referral volume, lab testing, and how practices document and bill colorectal cancer screening-related services. Understanding the coverage update helps practices reduce denials, avoid inappropriate patient charges, and align with both Medicare and commercial payer requirements.

Article Sections

1. Preventive services

   Overview of the colorectal cancer screening coverage expansion and its expected effects on patient access, referrals, and laboratory activity. Discusses the broader preventive service context and payer alignment.

2. What gastros need to know

   Operational considerations for gastroenterology practices related to post-positive screening colonoscopy, documentation, and patient cost-sharing. Covers how the change affects claim handling and practice workflow.

3. A new policy creates new challenges

   Common implementation issues practices may encounter with the updated screening benefit, including claim processing holds, cost-sharing transitions, and modifier use. Highlights potential administrative pitfalls and communication challenges.

4. Find a different way to describe a colonoscopy that follows a positive non-invasive test

   Terminology considerations for distinguishing colonoscopies performed after a positive screening test from other follow-up procedures. Explains why consistent labeling matters for internal communication and claims.